| Literature DB >> 27447653 |
Soon-Won Jung1, Kyoungho Lee2, Yong-Sung Cho3, Ji-Hee Choi4, Wonho Yang5, Tack-Shin Kang6, Choonghee Park7, Geun-Bae Kim8, Seung-Do Yu9, Bu-Soon Son10.
Abstract
Spatial interpolation is employed to improve exposure estimates and to assess adverse health effects associated with environmental risk factors. Since various studies have reported that high ozone (O₃) concentrations can give rise to adverse effects on respiratory symptoms and lung function, we investigated the association between O₃ levels and lung function using a variety of spatial interpolation techniques and evaluated how different methods for estimating exposure may influence health results for a cohort from an industrial complex (Gwangyang Bay) in South Korea in 2009. To estimate daily concentrations of O₃ in each subject, four different methods were used, which include simple averaging, nearest neighbor, inverse distance weighting, and kriging. Also, to compare the association between O₃ levels and lung function by age-groups, we explored ozone's impacts on three age-related groups: children (9-14 years), adults (15-64 years), and the elderly (≥65 years). The overall change of effect size on lung function in each age group tended to show similar patterns for lag and methods for estimating exposure. A significant negative association was only observed between O₃ levels and FVC and FEV₁ for most of the lag and methods in children. The largest effect of O₃ levels was found at the average for the lung function test day and last 2 days (0-2 days). In conclusions, the spatial interpolation methods may benefit in providing individual-level exposure with appropriate temporal resolution from ambient monitors. However, time-activity patterns of residents, monitoring site locations, methodological choices, and other factors should be considered to minimize exposure misclassification.Entities:
Keywords: kriging; lung function; ozone; spatial interpolation
Mesh:
Substances:
Year: 2016 PMID: 27447653 PMCID: PMC4962269 DOI: 10.3390/ijerph13070728
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1The locations of the study area and air monitoring stations.
Summary statistics comparing the result of the four different methods for daily O3 concentrations at the the Gwangyang Bay industrial complex (n = 2283).
| Model | Mean | SD | Min | 25th | 50th | 75th | Max |
|---|---|---|---|---|---|---|---|
| Method 1 | 42.2 | 15.5 | 10.4 | 30.1 | 39.4 | 54.0 | 88.6 |
| Method 2 | 40.9 | 16.6 | 3.7 | 28.9 | 38.9 | 51.8 | 113.8 |
| Method 3 | 41.4 | 15.6 | 3.8 | 29.7 | 39.0 | 52.2 | 113.1 |
| Method 4 | 41.7 | 15.9 | 5.9 | 29.6 | 39.2 | 52.6 | 113.5 |
Daily 8 h maximum moving average, Method 1: simple averaging, Method 2: nearest neighbor, Method 3: inverse distance weighting, Method 4: kriging.
Distributions of O3 concentrations measured on lung function test day, 1 day, 2 days, 0–1 day, 1–2 days and 0–2 days by the four different methods.
| Lag Days | Method 1 | Method 2 | Method 3 | Method 4 | ||||
|---|---|---|---|---|---|---|---|---|
| Mean (SD) | Range | Mean (SD) | Range | Mean (SD) | Range | Mean (SD) | Range | |
| 0 day | 59.8 (12.0) | 31.5–85.9 | 56.0 (14.6) | 26.0–85.7 | 57.8 (12.6) | 30.2–93.9 | 58.1 (13.0) | 31.5–97.8 |
| 1 day | 58.1 (11.7) | 35.8–82.8 | 53.9 (13.6) | 26.0–93.9 | 55.4 (12.1) | 30.9–93.4 | 55.7 (12.2) | 30.0–98.2 |
| 2 days | 58.9 (12.2) | 28.3–85.0 | 56.2 (12.3) | 24.0–96.4 | 57.7 (12.5) | 24.0–90.5 | 57.9 (12.3) | 23.9–90.1 |
| 0–1 day | 58.9 (10.6) | 36.7–84.4 | 54.9 (12.7) | 30.0–95.4 | 56.6 (10.8) | 33.5–93.6 | 56.9 (11.0) | 36.3–91.6 |
| 1–2 days | 58.5 (10.7) | 32.0–81.8 | 55.0 (11.2) | 26.8–93.6 | 56.6 (10.9) | 27.9–89.6 | 56.8 (10.8) | 27.3–88.3 |
| 0–2 days | 58.9 (9.8) | 36.2–83.2 | 55.3 (10.7) | 34.1–90.7 | 57.0 (9.8) | 34.7–89.0 | 57.2 (9.9) | 34.7–87.2 |
Method 1: simple averaging, Method 2: nearest neighbor, Method 3: inverse distance weighting, Method 4: kriging, SD: standard deviation, 0 day: lung function test day, 1 day: 1 day before lung function test, 2 days: 2 days before lung function test, 0–1 day: average of the test day and previous day, 1–2 days: average of the last 2 days, 0–2 days: average of the test day and last 2 days.
Results from cross-validation data in this study.
| Pollutant | Method | RMSE | COD |
|---|---|---|---|
| O3 | Nearest monitor | 10.5 | 0.139 |
| O3 | IDW | 8.75 | 0.113 |
| O3 | Kriging | 7.48 | 0.099 |
RMSE: root mean square error, COD: coefficient of divergence.
Demographic characteristics of the study subjects.
| Variables | All | Age 9–14 | Age 15–64 | Age ≥ 65 | |
|---|---|---|---|---|---|
|
| 2283 | 200 | 1419 | 664 | |
| Age (years) | 41.8 ± 25.7 | 12.8 ± 1.23 | 30.7 ± 17.8 | 74.2 ± 5.60 | |
| Gender (%) | Male | 43.1 | 47.5 | 46.5 | 34.5 |
| Female | 56.9 | 52.5 | 53.5 | 65.5 | |
| Height (cm) | 158.7 ± 10.0 | 145.4 ± 8.50 | 162.3 ± 8.57 | 155.2 ± 8.52 | |
| Weight (kg) | 55.6 ± 12.3 | 37.8 ± 9.89 | 57.4 ± 11.6 | 57.1 ± 9.90 | |
| BMI (kg/m2) | 21.9 ± 3.89 | 17.6 ± 3.53 | 21.7 ± 3.70 | 23.6 ± 3.25 | |
| Lung function | FEV1 (L) | 2.37 ± 0.73 | 1.92 ± 0.35 | 2.69 ± 0.66 | 1.82 ± 0.55 |
| FVC (L) | 2.90 ± 0.84 | 2.26 ± 0.42 | 3.23 ± 0.76 | 2.39 ± 0.71 | |
| FEV1/FVC (%) | 81.6 ± 8.76 | 85.5 ± 6.57 | 83.4 ± 7.65 | 76.6 ± 9.48 |
BMI: body mass index, FVC: forced vital capacity, FEV1: forced expiratory flow in 1 s.
Figure 2Change of FVC (L) by O3 concentration for various lags and methods for estimating exposure.
Figure 3Change of FEV1 (L) by O3 concentration for various lags and methods for estimating exposure.
Age-specific effect of change in FVC (L) per increase IQR † of O3 concentration by various lags and four methods for estimating exposure.
| Lag Day | Age | FVC (L) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Method 1 | Method 2 | Method 3 | Method 4 | ||||||
| β | (95% CI) | β | (95% CI) | β | (95% CI) | β | (95% CI) | ||
| 0 day | 9–14 | −0.12 | (−0.21, −0.03) * | −0.00 | (−0.07, 0.07) | −0.01 | (−0.07, 0.06) | −0.02 | (−0.10, 0.06) |
| 15–64 | −0.02 | (−0.06, 0.03) | 0.01 | (−0.03, 0.05) | 0.01 | (−0.02, 0.05) | 0.02 | (−0.02, 0.07) | |
| ≥65 | −0.04 | (−0.10, 0.01) | −0.03 | (−0.09, 0.03) | −0.02 | (−0.07, 0.03) | −0.03 | (−0.09, 0.04) | |
| All | 0.03 | (−0.01, 0.07) | −0.00 | (−0.04, 0.03) | 0.02 | (−0.01, 0.05) | 0.03 | (−0.01, 0.06) | |
| 1 day | 9–14 | −0.09 | (−0.15, −0.03) * | −0.08 | (−0.13, −0.03) * | −0.09 | (−0.14, −0.04) * | −0.11 | (−0.17, −0.04) * |
| 15–64 | −0.04 | (−0.09, 0.01) | 0.01 | (−0.03, 0.05) | −0.02 | (−0.06, 0.03) | −0.02 | (−0.08, 0.03) | |
| ≥65 | 0.00 | (−0.05, 0.06) | −0.03 | (−0.08, 0.03) | −0.00 | (−0.05, 0.04) | −0.01 | (−0.07, 0.05) | |
| All | 0.04 | (−0.00, 0.07) | 0.03 | (−0.00, 0.07) | 0.03 | (−0.01, 0.06) | 0.04 | (0.00, 0.09) | |
| 2 days | 9–14 | −0.10 | (−0.15, −0.05) ** | −0.11 | (−0.16, −0.06) ** | −0.09 | (−0.13, −0.05) ** | −0.11 | (−0.16, −0.06) ** |
| 15–64 | 0.02 | (−0.03, 0.07) | −0.01 | (−0.06, 0.04) | −0.01 | (−0.05, 0.03) | 0.02 | (−0.04, 0.08) | |
| ≥65 | −0.01 | (−0.06, 0.05) | −0.03 | (−0.10, 0.04) | −0.01 | (−0.06, 0.04) | −0.01 | (−0.07, 0.05) | |
| All | 0.07 | (0.03, 0.10) | 0.05 | (0.01, 0.09) | 0.04 | (0.01, 0.07) | 0.07 | (0.03, 0.12) | |
| 0–1 day | 9–14 | −0.11 | (−0.19, −0.04) * | −0.06 | (−0.13, 0.00) | −0.07 | (−0.14, −0.01) * | −0.09 | (−0.17, −0.01) * |
| 15–64 | −0.04 | (−0.09, 0.02) | 0.01 | (−0.03, 0.06) | 0.00 | (−0.04, 0.05) | 0.01 | (−0.05, 0.06) | |
| ≥65 | −0.02 | (−0.08, 0.03) | −0.03 | (−0.10, 0.03) | −0.01 | (−0.06, 0.04) | −0.02 | (−0.09, 0.05) | |
| All | 0.04 | (−0.00, 0.08) | 0.02 | (−0.02, 0.06) | 0.03 | (−0.01, 0.07) | 0.05 | (−0.00, 0.09) | |
| 1–2 days | 9–14 | −0.11 | (−0.17, −0.06) ** | −0.11 | (−0.16, −0.06) ** | −0.10 | (−0.15, −0.05) ** | −0.12 | (−0.18, −0.07) ** |
| 15–64 | −0.02 | (−0.07, 0.04) | 0.00 | (−0.05, 0.06) | −0.02 | (−0.07, 0.03) | −0.00 | (−0.07, 0.06) | |
| ≥65 | −0.00 | (−0.060, 0.057) | −0.04 | (−0.11, 0.03) | −0.01 | (−0.06, 0.04) | −0.01 | (−0.08, 0.06) | |
| All | 0.07 | (0.02, 0.11) | 0.05 | (0.01, 0.10) | 0.05 | (0.01, 0.08) | 0.07 | (0.02, 0.12) | |
| 0–2 days | 9–14 | −0.13 | (−0.20, −0.06) ** | −0.11 | (−0.18, −0.04) * | −0.12 | (−0.18, −0.05) ** | −0.14 | (−0.22, −0.07) ** |
| 15–64 | −0.03 | (−0.09, 0.04) | 0.01 | (−0.05, 0.06) | −0.00 | (−0.06, 0.05) | 0.02 | (−0.05, 0.08) | |
| ≥65 | −0.02 | (−0.08, 0.04) | −0.04 | (−0.12, 0.03) | −0.01 | (−0.07, 0.04) | −0.02 | (−0.09, 0.05) | |
| All | 0.07 | (0.02, 0.11) | 0.04 | (−0.01, 0.08) | 0.05 | (0.01, 0.09) | 0.07 | (0.02, 0.12) | |
†: IQR is 17.3 ppb for O3, FVC: forced vital capacity, Method 1: simple averaging, Method 2: nearest neighbor, Method 3: inverse distance weighting, Method 4: kriging, CI: confidence interval, 0 day: lung function test day, 1 day: 1 day before lung function test, 2 days: 2 days before lung function test, 0–1 day: average of the test day and previous day, 1–2 days: average of the last 2 days, 0–2 days: average of the test day and last 2 days. **: p < 0.001, *: p < 0.05.
Age-specific effect of change in FEV1 (L) per increase IQR † of O3 concentration by various lags and four methods for estimating exposure.
| Lag Day | Age | FEV1 (L) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Method 1 | Method 2 | Method 3 | Method 4 | ||||||
| β | (95% CI) | β | (95% CI) | β | (95% CI) | β | 95% CI | ||
| 0 day | 9–14 | −0.12 | (−0.20, −0.04) * | −0.02 | (−0.08, 0.04) | −0.03 | (−0.08, 0.03) | −0.04 | (−0.11, 0.03) |
| 15–64 | −0.00 | (−0.04, 0.04) | 0.02 | (−0.01, 0.05) | 0.03 | (−0.00, 0.06) | 0.04 | (0.00, 0.08) | |
| ≥65 | −0.07 | (−0.12, −0.03) * | −0.07 | (−0.11, −0.02) * | −0.06 | (−0.10, −0.02) * | −0.07 | (−0.12, −0.02) * | |
| All | 0.02 | (−0.01, 0.06) | −0.01 | (−0.04, 0.02) | 0.02 | (−0.01, 0.04) | 0.02 | (−0.01, 0.05) | |
| 1 day | 9–14 | −0.09 | (−0.14, −0.04) * | −0.07 | (−0.12, −0.03) * | −0.08 | (−0.12, −0.04) * | −0.10 | (−0.15, −0.04) * |
| 15–64 | −0.03 | (−0.08, 0.01) | 0.02 | (−0.02, 0.06) | −0.00 | (−0.04, 0.03) | −0.01 | (−0.06, 0.04) | |
| ≥65 | −0.02 | (−0.07, 0.02) | −0.02 | (−0.07, 0.03) | −0.02 | (−0.06, 0.02) | −0.02 | (−0.07, 0.02) | |
| All | 0.02 | (−0.01, 0.06) | 0.04 | (0.00, 0.07) | 0.03 | (−0.00, 0.05) | 0.04 | (0.00, 0.07) | |
| 2 days | 9–14 | −0.08 | (−0.12, −0.04) * | −0.08 | (−0.13, −0.04) * | −0.07 | (−0.11, −0.03) * | −0.08 | (−0.13, −0.04) * |
| 15–64 | 0.05 | (0.00, 0.09) | 0.02 | (−0.02, 0.07) | 0.02 | (−0.02, 0.06) | 0.05 | (0.00, 0.10) | |
| ≥65 | −0.05 | (−0.09, −0.01) * | −0.05 | (−0.11, 0.00) | −0.04 | (−0.08, −0.00) * | −0.05 | (−0.10, −0.00) * | |
| All | 0.06 | (0.03, 0.09) | 0.06 | (0.02, 0.09) | 0.04 | (0.01, 0.07) | 0.06 | (0.03, 0.10) | |
| 0–1 day | 9–14 | −0.11 | (−0.18, −0.04) * | −0.06 | (−0.12, −0.01) * | −0.08 | (−0.13, −0.02) * | −0.10 | (−0.16, −0.03) * |
| 15–64 | −0.02 | (−0.07, 0.03) | 0.02 | (−0.02, 0.06) | 0.02 | (−0.02, 0.06) | 0.03 | (−0.02, 0.08) | |
| ≥65 | −0.06 | (−0.10, −0.01) * | −0.06 | (−0.11, −0.00) * | −0.04 | (−0.09, 0.00) | −0.06 | (−0.11, −0.00) * | |
| All | 0.03 | (−0.01, 0.07) | 0.02 | (−0.02, 0.05) | 0.03 | (−0.01, 0.06) | 0.04 | (−0.00, 0.08) | |
| 1–2 days | 9–14 | −0.10 | (−0.15, −0.05) ** | −0.09 | (−0.14, −0.04) * | −0.08 | (−0.13, −0.04) ** | −0.10 | (−0.15, −0.05) ** |
| 15–64 | 0.01 | (−0.04, 0.06) | 0.03 | (−0.02, 0.08) | 0.01 | (−0.03, 0.05) | 0.03 | (−0.03, 0.08) | |
| ≥65 | −0.04 | (−0.09, 0.00) | −0.05 | (−0.11, 0.01) | −0.04 | (−0.08, 0.01) | −0.05 | (−0.10, 0.01) | |
| All | 0.05 | (0.02, 0.09) | 0.06 | (0.02, 0.10) | 0.04 | (0.01, 0.07) | 0.06 | (0.02, 0.10) | |
| 0–2 days | 9–14 | −0.12 | (−0.18, −0.06) ** | −0.10 | (−0.16, −0.04) * | −0.10 | (−0.16, −0.05) * | −0.12 | (−0.19, −0.06) ** |
| 15–64 | 0.01 | (−0.05, 0.06) | 0.03 | (−0.01, 0.08) | 0.03 | (−0.02, 0.08) | 0.05 | (−0.01, 0.11) | |
| ≥65 | −0.06 | (−0.11, −0.01) * | −0.07 | (−0.13, −0.01) * | −0.05 | (−0.09, −0.00) * | −0.06 | (−0.12, −0.01) * | |
| All | 0.05 | (0.01, 0.09) | 0.04 | (−0.00, 0.08) | 0.04 | (0.01, 0.08) | 0.06 | (0.02, 0.11) | |
†: IQR is 17.3 ppb for O3, FEV1: forced expiratory flow in 1 s, Method 1: simple averaging, Method 2: nearest neighbor, Method 3: inverse distance weighting, Method 4: kriging, 0 day: lung function test day, 1 day: 1 day before lung function test, 2 days: 2 days before lung function test, 0−1 day: average of the test day and previous day, 1−2 days: average of the last 2 days, 0−2 days: average of the test day and last 2 days. **: p < 0.001, *: p < 0.05.